News/ Novartis/ Sales and Marketing Novartis bullish about future despite Gleevec pain Andrew McConaghie Gleevec 0 Comment The patent loss of its biggest earning drug has hit Novartis’ revenues, which fell 1% in the third Share X Novartis bullish about future despite Gleevec pain https://pharmaphorum.com/news/novartis-bullish-future-despite-gleevec-pain/
